Robert A. Stull
45Patents
8h-index
19Co-inventors
72Inventor score
Filing activity: May 27, 1998 → Dec 6, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7723472B2 | Extracellular matrix binding chimeric proteins and methods of use thereof | Chemistry; Metallurgy | 21 | Active |
| US9089615B2 | Anti-DLL3 antibodies | Physics | 16 | Active |
| US8986972B2 | Nucleic acid encoding DLL3 antibodies | Physics | 16 | Active |
| US6322969A | Method for preparing permuted, chimeric nucleic acid libraries | Chemistry; Metallurgy | 13 | Expired |
| US9089617B2 | Anti-DLL3 antibody drug conjugates | Physics | 9 | Active |
| US9090683B2 | Methods of detection, diagnosis, and monitoring using anti-DLL3 antibodies | Physics | 8 | Active |
| US9358304B1 | Methods of making DLL3 antibody drug conjugates | Physics | 8 | Active |
| US9352051B1 | Kits containing DLL3 antibody drug conjugates | Physics | 8 | Active |
| US9353182B2 | Anti-DLL3 antibodies | Physics | 8 | Active |
| US9089616B2 | Anti-DLL3 antibody drug conjugates and methods of use | Physics | 8 | Active |
| US9133271B1 | Anti-DLL3 antibody drug conjugates and methods of use | Physics | 8 | Active |
| US9107961B2 | Anti-DLL3 antibody drug conjugates for treating cancer | Physics | 8 | Active |
| US9334318B1 | Multivalent DLL3 antibodies | Physics | 8 | Active |
| US9409995B2 | PTK7 modulators and methods of use | Chemistry; Metallurgy | 8 | Active |
| US9155803B1 | Anti-DLL3 antibody drug conjugates and methods of use | Physics | 8 | Active |
| US9764042B1 | Methods of making DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9931421B2 | Methods of delivering DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9937268B2 | Anti-DLL3 antibody drug conjugates and methods of use | Physics | 7 | Active |
| US9855343B2 | Anti-DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9878053B2 | Methods of delivering DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9867887B1 | Anti-DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9861708B2 | Kits containing DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9486537B2 | Anti-DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9931420B2 | Methods of making DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9770518B1 | Anti-DLL3 antibody drug conjugates | Physics | 7 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.